Total Equity - InnoCare Pharma Ltd (SSE:688428) - Alpha Spread

InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 11.33 CNY -2.16% Market Closed
Market Cap: 9.6B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

InnoCare Pharma Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InnoCare Pharma Ltd
Total Equity Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
SSE:688428
Total Equity
ÂĄ7.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Equity
ÂĄ25.1B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Equity
ÂĄ12.5B
CAGR 3-Years
13%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Total Equity
ÂĄ2.6B
CAGR 3-Years
-6%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Equity
ÂĄ12.7B
CAGR 3-Years
71%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Equity
ÂĄ31.5B
CAGR 3-Years
32%
CAGR 5-Years
47%
CAGR 10-Years
29%

See Also

What is InnoCare Pharma Ltd's Total Equity?
Total Equity
7.6B CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Total Equity amounts to 7.6B CNY.

What is InnoCare Pharma Ltd's Total Equity growth rate?
Total Equity CAGR 1Y
36%

Over the last year, the Total Equity growth was 36%.

Back to Top